1. Home
  2. DOMO vs ATYR Comparison

DOMO vs ATYR Comparison

Compare DOMO & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • ATYR
  • Stock Information
  • Founded
  • DOMO 2010
  • ATYR 2005
  • Country
  • DOMO United States
  • ATYR United States
  • Employees
  • DOMO N/A
  • ATYR N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DOMO Technology
  • ATYR Health Care
  • Exchange
  • DOMO Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • DOMO 332.0M
  • ATYR 330.7M
  • IPO Year
  • DOMO 2018
  • ATYR 2015
  • Fundamental
  • Price
  • DOMO $8.31
  • ATYR $3.70
  • Analyst Decision
  • DOMO Hold
  • ATYR Strong Buy
  • Analyst Count
  • DOMO 6
  • ATYR 6
  • Target Price
  • DOMO $10.42
  • ATYR $18.60
  • AVG Volume (30 Days)
  • DOMO 339.8K
  • ATYR 1.9M
  • Earning Date
  • DOMO 03-06-2025
  • ATYR 03-13-2025
  • Dividend Yield
  • DOMO N/A
  • ATYR N/A
  • EPS Growth
  • DOMO N/A
  • ATYR N/A
  • EPS
  • DOMO N/A
  • ATYR N/A
  • Revenue
  • DOMO $317,044,000.00
  • ATYR $235,000.00
  • Revenue This Year
  • DOMO $0.86
  • ATYR $1,387.23
  • Revenue Next Year
  • DOMO $1.94
  • ATYR $873.22
  • P/E Ratio
  • DOMO N/A
  • ATYR N/A
  • Revenue Growth
  • DOMO N/A
  • ATYR N/A
  • 52 Week Low
  • DOMO $6.11
  • ATYR $1.42
  • 52 Week High
  • DOMO $10.15
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 51.66
  • ATYR 54.37
  • Support Level
  • DOMO $8.12
  • ATYR $2.98
  • Resistance Level
  • DOMO $8.76
  • ATYR $4.32
  • Average True Range (ATR)
  • DOMO 0.47
  • ATYR 0.39
  • MACD
  • DOMO 0.07
  • ATYR 0.06
  • Stochastic Oscillator
  • DOMO 72.16
  • ATYR 72.14

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: